Based on our experimental results, we hypothesize that in ccRCC, IFI16 may directly bind to the promoter region of IL6, thereby enhancing its transcription and translation, and activating the PI3K/AKT signaling pathway. The gene discussed is IFI16; the disease is nonpapillary renal cell carcinoma.